VRDN EBITDA Margin
Viridian Therapeutics Ors Inc · EBITDA Margin
VRDN EBITDA Margin
Latest reported-516.78%period ending
VRDN TTM EBITDA Margin (-1.11% → -516.78%)
TTM ebitda margin
High-resolution chart · PNG
VRDN ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| -516.7784% | |
| -492.0923% | |
| -471.2459% | |
| -422.3679% | |
| -111,677.377% | |
| -100,914.5695% | |
| -88,199.6689% | |
| -83,911.5894% | |
| -78,049.6528% | |
| -74,754.8611% | |
| -74,957.0064% | |
| -61,986.1671% | |
| -13,390.8844% | |
| -10,360.399% | |
| -7,281.772% | |
| -5,976.7677% | |
| -10,934.7875% | |
| -5,000.9259% | |
| -2,677.8603% | |
| -2,537.3172% | |
| -2,406.6281% | |
| -3,035.8637% | |
| -3,823.1429% | |
| -1,463.4328% | |
| -1,286.0755% | |
| -719.6258% | |
| -871.3965% | |
| -1,007.863% | |
| -896.9577% | |
| -966.9602% | |
| -375.4591% | |
| -303.0872% | |
| -251.0369% | |
| -280.1441% | |
| -643.8921% | |
| -705.2705% | |
| -752.2124% | |
| -556.3905% | |
| -374.1384% | |
| -311.1728% | |
| -399.5091% | |
| -418.6947% | |
| -440.6065% | |
| -406.8344% | |
| -264.7853% | |
| -236.4303% | |
| -155.6364% | |
| -88.5962% | |
| -65.0964% | |
| -3.2122% | |
| -1.1097% |